首页> 外文期刊>Hospital pediatrics. >Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation
【24h】

Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation

机译:肠方预防阿片类药物引起的便秘的预防性处方相关因素

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Identify factors associated with the prophylactic prescription of a bowel regimen with an inpatient opioid prescription.METHODS: This was a retrospective cohort study from June i, 2013, to October 31, 2014 of pediatric inpatients prescribed an oral or intravenous opioid on the general medical/surgical floors. We identified patients with or without a prophylactic prescription of a bowel regimen. We obtained patient demographics, prescriber training level and service and used multivariate logistic regression to analyze the factors associated with prophylactic bowel regimen and opioid prescription.RESULTS: Of the 6682 encounters that met study criteria, only 966 (14.5%) encounters had prophylactic prescriptions. Patient factors associated with prophylactic prescription include increasing age (per year; odds ratio [OR] = 1.06, 95% confidence interval [CI] 1.05-1.07) and sickle cell diagnosis (OR = 3.19, 95% CI 2.08-4.91).
机译:目的:确定与预防性处方和住院阿片类药物处方相关的因素。方法:这是一项回顾性队列研究,研究对象是2013年6月1日至2014年10月31日对一般口服或静脉内阿片类药物的小儿住院患者医疗/外科地板。我们确定了有或没有肠方案的患者。我们获得了患者的人口统计学资料,开处方者的培训水平和服务,并使用多因素logistic回归分析了与预防性肠方案和阿片类药物处方相关的因素。结果:在符合研究标准的6682次遭遇中,只有966次(14.5%)遭遇了预防性处方。与预防性处方相关的患者因素包括年龄增长(每年;优势比[OR] = 1.06,95%置信区间[CI] 1.05-1.07)和镰状细胞诊断(OR = 3.19,95%CI 2.08-4.91)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号